in this issue
Markets :: Fine Chemicals/Biotech :: Industrial Biotech
Amyris narrows loss
9:11 AM MDT | August 11, 2014 | Rebecca Coons
Biobased farnesene firm Amyris (Emeryville, CO) reports a second-quarter net loss of $35.5 million, compared to a net loss of $38.9 million in the year-ago quarter. Sales slipped 14.2%, to $9.3 million. Renewable product sales revenue was $4.4 million, a 5.4% increase over the second quarter of 2013. Recognized grants and collaborations revenues were $4.9 million on a GAAP basis. Expanded isoprene collaboration with addition of a new partner, Braskem, and added first cosmetic product collaboration with Natura, BioAmber says. "With two new...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee